Alto Neuroscience
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -184 | -157 | -164 |
EBITDA | -25,508 | -15,450 | -13,367 |
EBIT | -25,692 | -15,607 | -13,531 |
Net Income | -26,237 | -16,182 | -14,181 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -27,647 | -11,516 | -9,918 |
Cash | 263,762 | 176,484 | 137,816 |
Basic Shares | 32,893 | 31,923 | 27,104 |
Annual Financials
| Values in thousands | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -661 | -502 | -373 | -342 |
EBITDA | -60,108 | -62,304 | -34,562 | -27,368 |
EBIT | -60,769 | -62,806 | -34,935 | -27,710 |
Net Income | -63,238 | -61,431 | -36,305 | -27,710 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -51,793 | -49,499 | -33,918 | -21,126 |
Cash | 176,484 | 168,229 | 82,548 | 48,344 |
Basic Shares | 28,852 | 24,602 | 26,883 | 25,574 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.65 |
2026-03-31 | -$0.80 |
2025-12-31 | -$0.45 |
2025-09-30 | -$0.52 |